Technology · 1 sources covering this

We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It

The replica watch industry is in its “super clone” era. Following tips from murky internet forums, we bought three budget fakes that were good enough to pass as real—but ultimately disposable.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

WIREDLean L·1h ago
We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It
The replica watch industry is in its “super clone” era. Following tips from murky internet forums, we bought three budget fakes that were good enough to pass as real—but ultimately disposable.
Read at WIRED →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/cc5de8694aa72bcf9ecee175dd5d7d6663572227"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It"></iframe>

We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It

How 1 sources are covering this

We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It

More from Technology

You can Venmo your college tuition, for some reason

AI isn’t close to curing cancer. This startup says it knows what it will take.

The Best Digital Wall Calendar (2026): Skylight, Everblog, Apolosign

U.S. retreat from global order ‘eroding’ European competitiveness, central bank boss warns

Reader

Trust & legal

Across the network

How 1 sources are covering this

We Bought a $500 Counterfeit Rolex So Good, Even Rolex Didn’t Spot It

More from Technology

You can Venmo your college tuition, for some reason

AI isn&#8217;t close to curing cancer. This startup says it knows what it will take.

The Best Digital Wall Calendar (2026): Skylight, Everblog, Apolosign

U.S. retreat from global order ‘eroding’ European competitiveness, central bank boss warns

Reader

Trust & legal

Across the network

AI isn’t close to curing cancer. This startup says it knows what it will take.